EN PL
ORIGINAL PAPER
HLA-B27 and HLA-DR: prognostic factors in systemic onset juvenile idiopathic arthritis
 
More details
Hide details
 
Online publication date: 2011-03-16
 
 
Reumatologia 2011;49(1):23-31
 
KEYWORDS
ABSTRACT
The genetic factors that predispose to the development of systemic onset juvenile idiopathic arthritis (SOJIA) and its complications are not completely understood. The clinical SOJIA is different among individual patients. In the present study we have analyzed the influence of HLA-B27 and HLA-DR antigen on the disease progression, extraarticular manifestations and development of amyloidosis in 47 SOJIA patients with a long disease duration (mean 18 ±7.4 years). The main outcome measures were radiological changes, functional disability, severity of the joint disease and the presence of amyloidosis confirmed by biopsy. Each patient was graded also for severity of the systemic disease observed in the course of the disease. The statistically significant increase in the incidence of HLA-DR4 was observed in the subgroup of patients with radiological evidence of joint destruction in comparison with controls (73.7 vs. 23.6%, p < 0.0001) and patients without such changes (73.7 vs. 25%, p < 0.005) (Fig. 4). Significant differences were observed also in patients with the most severe joint disease compared with controls (63 vs. 24%, p < 0.001) (Fig. 2). Additionally, the increase in frequency of HLA-DR3 was found in patients with severe systemic symptoms persisting or recurring for more than 2 years when compared with controls (76.2 vs. 23.6%, p < 0.0001) and patients with systemic features persisting or recurring up to 2 years of the disease duration (76.2 vs. 22.7%, p < 0.001) (Fig. 1). No correlation between HLA frequencies and functional status or the presence of amyloidosis was found. Conclusion: HLA typing may be valuable for predicting joint destruction and severity of systemic manifestation of SOJIA.
 
REFERENCES (32)
1.
Schneider R, Aexer RM. Systemic Juvenile Idiopatic Arthritis. In: Handbook of Systemic Autoimmune Disease, Climaz R, Leihman T (eds.). Elsevier BV, Philadelphia 2008; 6: 35-54.  .
 
2.
Musiej-Nowakowska E, Woźniak J. Młodzieńcze idiopatyczne zapalenie stawów o początku uogólnionym – przebieg choroby. Reumatologia 2008; 46: 313-321.  .
 
3.
Bedford PA, Ansell BM, Hall PJ, Woo P. Increased frequency of DR4 in systemic onset juvenile chronic arthritis. Clin Exp Rheumatol 1992; 10: 189-193.  .
 
4.
Desaymard C, Kaplan C, Fournier C, et al. Etude des marqueurs du systěme majeur d`histocompatibilite et de l`hétérogénéité clinicque de la forme systěmique d`arthrite chronique juvenile. Rev Rhum (Ed Fr) 1996; 63: 11-18.  .
 
5.
Glass DN, Litvin DA. Heterogeneity of HLA associations in systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1980; 23: 796-799.  .
 
6.
Miller ML, Aaron S, Jackson J. HLA gene frequencies in children and adults with systemic onset juvenile rheumatoid arthritis. Arthritis Rheum 1985; 28: 146-150.  .
 
7.
Morling N, Friis J, Heilmann C, et al. HLA antigens frequencies in juvenile chronic arthritis. Scand J Rheumatol 1985; 14: 209-216.  .
 
8.
Okubo H, Itou K, Tanaka S, et al. Analysis of the HLA-DR gene frequencies in Japanese cases of juveniles rheumatoid arthritis and rheumatoid arthritis by aligonucleotide DNA typing. Rheumatol Int 1993; 13: 65-69.  .
 
9.
Singh G, Mehra NU, Taneja V, et al. Histocompatibility antigents in systemic onset juvenile rheumatoid arthritis (letter). Arthritis Rheum 1989; 32: 1492-1495. .
 
10.
Date Y, Seki N, Kamizono S, et al. Identification of a genetic factor systemic juvenile rheumatoid arthritis in the 5 flanking region of the TNF-αlpha gene and HLA genes. Arthritis Rheum 1999; 42: 2577-2582. .
 
11.
Musiej-Nowakowska E, Rusiniak B. HLA u chorych na młodzieńcze idiopatyczne zapalenie stawów o uogólnionym początku. Reumatologia 2008; 46: 266-271. .
 
12.
Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2001; 31: 390-392. .
 
13.
Sterinbrocker O, Traeger CM, Batterman RC. Therapeutic Criteria in rheumatoid arthritis JAMA 1949; 140: 659-662. .
 
14.
Amos D, Bashir H, Boyle W, et al. A simple microcytotoxicity test. Transplantation 1969; 7: 220-223. .
 
15.
Płoski R, Főrre O/. Non-HLA genes and susceptibility to juvenile chronic arthritis. Clin Exp Rheumatol 1999; 12 (suppl 10): 15-17. .
 
16.
Bukulmez H, File M, Tsoras M et. al. Tapasin gene polymorphism in systemic onset juvenile rheumatoid arthritis: a family-based case – control study. Arthritis Res Ther 2005; 7: R285-290. .
 
17.
Stock CL, Ogilivie EM, Samuel M, et al. Comprehensive association study of genetic wariants in the IL-1 gene family in systemic juvenile idiophatic arthritis. Genes Immun 2008; 9: 349-357. .
 
18.
De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the – 173 polymorphism of the macrophage inhibitory factor gene in systemic onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48: 1398-1407. .
 
19.
Ogilive EM, Fife MS, Thompson SD, et al. The – 174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a mulitcenter study using simples and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 2003; 48: 3202-3206. .
 
20.
Ogilivie EM, Khan A, et al. Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 1954-1965. .
 
21.
Barnes MG, Grom AA, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic. Arthritis Rheum 2009; 60: 2102-2112. .
 
22.
Prahalad S, Glass DN. A comprehensive review of the genetics of juvenile idiopathic arthritis. Pediatric Rheumatology 2008; 6: 11-16. .
 
23.
Fraser PA, Stern S, Larsen MG. HLA – extended haplotypes in childhood and adult onset HLA-DR4 – associated arthro­pathies. Tissue Antigens 1990; 35: 56-59. .
 
24.
Calin A, Elswood J, Klouda PT. Destructive arthritis, rheumatoid factor, and HLA-DR4. Suscebility versus severity, a case control study. Arthritis Rheum 1989; 32: 1221-1225. .
 
25.
Weyand CM, Hicok KC, Conn DL, et al. The Influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992; 117: 801-806. .
 
26.
Maury CPJ, Teppo AM, Wafin F, et al. Class – specific factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis. Ann Rheum Dis 1988; 47: 546-552. .
 
27.
Mączyńska B, Filipowicz-Sosnowska A, Jesień-Dudzińska E. Antygeny układu HLA u chorych z amyloidozą reaktywną w przebiegu reumatoidalnego zapalenia stawów (RZS) i ze­sztywniającego zapalenia stawów kręgosłupa (ZZSK). Reumatologia 1991; 29: 151-150. .
 
28.
Pasternak A, Tiilikainen A. HLA-B27 in rheumatoid arthritis and amyloidosis. Tissue Antigens 1977; 9: 80-89. .
 
29.
Wafin F, Wegelius O, Falck H, Koskimies S. The HLA anigens in patiens with amyloidosis secondary to rheumatic diseases. In: Amyloid and Amyloidosis. Glenner GG, Costa PP (eds). Excerpta Medica, Amsterdam: 1980; 205-206. .
 
30.
Burman SJ, Hall PJ, Bedford A, et al. HLA antigens frequencies among patients with juvenile chronic arthritis and amyloidosis: a brief report. Clin Exp Rheumatol 1986; 4: 261-263. .
 
31.
Savolainen HA, Lehtimäk M, Kautiainen H, et al. HLA B27: A prognostic factor in juvenile chronic arthritis. Clin Rheumatol 1998; 17: 121-124. .
 
32.
Schuchmann L, Michels H, Renaud M, Renz K. Die Amyloidose eine gefürchtete Folgekrankheit der juvenilen chronischen arthritis. Klin Päd 1981; 193: 67-72.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top